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It was previously demonstrated that C3bi- but not IgG-mediated phagocytosis in human neutrophils is a Ca*+-indepen- 
dent process [(1985) Nature 315, 50%511]. The objective of this study was to elucidate the nature of an additional mes- 
senger signal(s) that may be involved in receptor-mediated phagocytosis in these cells. The C3bi- and IgG-mediated pha- 
gocytic ability of neutrophils was inhibited by forskolin, a potent activator of adenylate cyclase. It was found that forskol- 
in induced a 3-fold increase in CAMP levels and simultaneously reduced the uptake of both C3bi- and IgG-opsonized 
particles by 65%. This inhibition was reversed by exposure to either phorbol myristate acetate (PMA) or diacylglycerol 
(OAG), which are both activators of protein kinase C, but not by the inactive analog 4x-PMA. PMA could also restore 
the phagocytic ability of neutrophils with an experimentally impaired calcium response. These results suggest that activa- 
tion of protein kinase C might be an important transducing signal controlling receptor-mediated phagocytosis in human 
neutrophils. 
Protein kinase C; Phagocytosis; (Human neutrophil) 
1. INTRODUCTION 
The phagocytic process of human neutrophils is 
triggered by two major receptor-mediated 
mechanisms: one which recognizes the C3bi- 
fragment of the complement system and another 
which recognizes the Fc domain of im- 
munoglobulin G [l]. The nature of the 
mechanisms that control phagocytosis in human 
neutrophils is not clear. On the other hand, soluble 
stimuli, including chemotactic factors, induce an 
Correspondence address: T. Andersson, Department of Cell 
Biology, University of Linkoping, S-581 85 Linkoping, Sweden 
* Present address: Department of Cell Biology, University of 
Linkoping, 581 85 Linkoping, Sweden 
Abbreviations: fMet-Leu-Phe, formylmethionylleucylphenyl- 
alanine; InsP,, inositol trisphosphate; 1,4,5-InsPs, inositol 
1,4,5_trisphosphate; PMA, phorbol 12-myristate 13-acetate; 
4~PMA, 4cu-phorbol 12-myristate 13-acetate; OAG, l-oleoyl- 
2-acetylglycerol; [Ca’+]i, cytosolic free calcium concentration 
immediately increased activity of phospholipase C. 
This enzyme causes hydrolysis of phosphatidyl- 
inositol 4,5bisphosphate, resulting in a corre- 
sponding increase in the production of two well- 
known second messengers, namely, inositol 1,4,5- 
trisphosphate (Ins (1,4,5)P3) and 1 ,Zdiacylglycerol 
[2-61. The former induces mobilization of in- 
tracellular Ca’+, whereas the latter binds to and ac- 
tivates protein kinase C [2,3]. 
Protein kinase C is generally considered to act in 
concert with calcium as a transducing signal for a 
number of chemotactic stimuli. 
In two independent studies on C3bi- and IgG- 
mediated phagocytosis a concomitant elevation in 
the concentration of cytosolic free calcium has 
been clearly demonstrated [7-91. An increase in 
concentration of cytosolic free calcium appears to 
be required for ingestion of IgG-coated particles 
by human neutrophils, whereas an elevation of 
calcium is not at all essential for the engulfment of 
C3bi-opsonized particles [8]. Because the process 
of engulfment can be accomplished in cells with a 
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reduced concentration of cytosolic free calcium 
(less than 20 nM), the involvement of an alter- 
native messenger signal participating in the initia- 
tion and regulation of receptor-mediated 
phagocytosis is necessary. Based on these and 
other observations, it is at present suspected that 
increased turnover of the inositol cycle and activa- 
tion of protein kinase C may be involved in 
receptor-mediated phagocytosis [ 10,111. 
Consequently, the objective of this study was to 
investigate whether protein kinase C can function 
as a transducing signal for receptor-mediated 
phagocytosis in human neutrophils. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Materials and their sources were as follows, forskolin 
(Calbiochem, La Jolla, CA); quin2/AM, quin2 and prostaglan- 
din Et (Amersham, Bucks); fMet-Leu-Phe, OAG, and PMA 
(Sigma, St. Louis, MO); 4cu-PMA (LC Serv. Corp., Woburn, 
MA); dextran, and Ficoll-Hypaque (Pharmacia, Uppsala). 
2.2. Preparation of cells 
Blood was obtained from healthy volunteers and collected in 
heparin-containing tubes. Whole blood was allowed to sedi- 
ment in dextran, after which the neutrophils were isolated ac- 
cording to Boyum [12]. Contaminating erythrocytes were 
eliminated by 20 s hypotonic lysis in distilled water, after which 
the cells were washed twice before being suspended in a 
calcium-containing medium [this medium included: 138 mM 
NaCI, 6 mM KCl, 1 mM MgS04, 1.1 mM CaCb, 0.1 mM 
EGTA, 1 mM NaHPO+ 5 mM NaHC03,5.5 mM glucose, and 
20 mM Hepes (pH 7.4)]. 
2.3. Determination of CAMP content 
Human neutrophils (lO’/ml) were incubated with forskolin 
(100pM) for various periods of time at 37°C. The reactions 
were terminated by adding ice-cold ethanol (final concentration 
65%). The different samples were then allowed to settle for 1 h 
at -2O”C, after which the different supernatants containing 
CAMP were collected. The precipitated materials were washed 
in fresh 65% ice-cold ethanol to ensure that the extraction of 
CAMP was as complete as possible. The supernatants were then 
centrifuged at 2000 x g for 15 min at 4”C, and the precipitates 
were discarded. The remaining supernatants were then 
evaporated under nitrogen, after which the CAMP content was 
determined with a commercial CAMP assay kit (Amersham). 
2.4. Determination of phagocytosis 
Phagocytosis of FITC-labelled yeast particles was monitored 
by a fluorescence quenching method [8,13], in which the ex- 
tracellular particles are quenched by addition of trypan blue. 
The IgG-coated particles were opsonized by incubating yeast 
with purified anti-yeast IgG (24 pg/ml) in the presence of 20% 
heat-inactivated (56”C, 30 min) human serum; C3bi-coated 
particles were opsonized by incubating the yeast with 20% fresh 
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human serum. All particles were opsonized by incubation at 
37OC for 30 min and washed before use. Phagocytic activity for 
each condition was determined by calculating the number of 
yeast particles ingested per 100 cells. 
3. RESULTS AND DISCUSSION 
It is well known that CAMP can inhibit receptor- 
induced responses, including motile events such as 
chemotaxis and phagocytosis, in neutrophils 
[14-161. Here, forskolin, a potent activator of 
adenylate cyclase [ 171, was used to raise the in- 
tracellular content of CAMP. Control cells con- 
tained 560 fmol cAMP/106 cells. 10 min after the 
addition of forskolin, the cellular content of 
CAMP was increased 3-fold (312%, mean of 3 ex- 
periments). This level was maintained for at least 
50 min, during which various experimental 
measurements were made. The forskolin-induced 
rise in cellular CAMP resulted in a 60-65% reduc- 
tion of both C3bi- and IgG-mediated phagocytosis 
(figs 1,2). Prostaglandin Ei (10 ,uM), whose effects 
are mediated by CAMP [18,19], inhibited IgG- and 
C3bi-mediated phagocytosis 69 and 45% (n = 3), 
respectively. Therefore, it seems reasonable to 
assume that the observed forskolin-induced inhibi- 
tion of phagocytosis is mediated by an elevation of 
cellular CAMP levels. However, it is not known 
whether the effects of CAMP on receptor-mediated 
phagocytosis are mediated by: (i) phosphorylation 
and inactivation of a pertinent receptor; and/or (ii) 
phosphorylation and inhibition of a cytoskeletal 
protein; and/or (iii) inhibition of phospholipase C 
and suppression of second messenger levels. The 
last alternative is supported by the fact that eleva- 
tion of CAMP leads to the reduced formation of 
receptor-mediated intracellular messengers from 
the phosphoinositide cycle in thrombocytes and 
human neutrophils [20,21]. In addition, we have 
recently been able to demonstrate that forskolin in- 
hibited C3bi- and IgG-mediated formation of 
second messengers derived from the inositol cycle 
in human neutrophils (Fallman et al., unpublished). 
It is therefore suggestive that the PMA- and OAG- 
induced restoration of receptor-mediated phago- 
cytosis (figs 1,2) may best be explained by the 
postulate that PMA and OAG substitute for the 
endogenously derived diacylglycerol in activating 
protein kinase C. This role for protein kinase C is 
further supported by the observation that 4~ 
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Fig.1. Restoring effects of PMA and OAG on forskolin- 
inhibited phagocytosis of C3bi-particles in human neutrophils. 
Cells were pre-incubated with forskolin (100/zM) for 30 min at 
37°C. This concentration of forskolin was also maintained 
during the 20 min incubation with C3bi-opsonized yeast 
particles, which was followed by counting of the number of 
phagocytosed particles. In experiments studying the 
modulatory effects of PMA (10 -7 M , hatched bar) and OAG 
(10 -4 M, dotted bar), the additives were given during the last 
10min of the pre-incubation with forskolin and also 
maintained during the subsequent incubation with C3bi- 
opsonized yeast particles. Values given are means + SE of 6-8 
separate experiments. The 10007o level for C3bi-mediated 
phagocytosis was 186 _+ 20 yeast particles/100 cells. PMA or 
OAG alone did not affect C3bi-mediated phagocytosis; 97 _+ 6 
and 112 _+ 807o f control, respectively. Statistically significant 
modulation by PMA and OAG is indicated. The statistical test 
was performed using Student's t-test for paired samples. 
** P < 0.01. 
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Fig.2. Restoring effects of PMA and OAG on forskolin- 
inhibited phagocytosis of IgG-particles in human neutrophils. 
Cells were pre-incubated with forskolin (100/zM) for 30 min at 
37°C, This concentration of forskolin was also maintained 
during the 20 min incubation with IgG-opsonized yeast 
particles, which was followed by counting the number of 
phagocytosed particles. In experiments studying the 
modulatory effects of PMA (10 -7 M, hatched bar) and OAG 
(10 -4 M, dotted bar), the additives were given during the last 
10 min of the pre-incubation and also maintained uring the 
subsequent incubation with opsonized yeast particles. Values 
given are means _+ SE of 6-9 separate xperiments. The 100%0 
level for IgG-mediated phagocytosis was 201 _+ 30 yeast 
particles/100 cells. PMA alone only modestly affected lgG- 
mediated phagocytosis (73 _+ 7% of control), whereas OAG 
alone had no significant effect (113 ___ 9% of control). 
Statistically significant modulations by PMA and OAG are 
indicated. The statistical tests were performed using Student's 
t-test for paired samples. ** P < 0.01; *** P < 0.001. 
PMA,  a phorbo l  ester  that  does  not  ac t ivate  pro-  
te in  k inase  C,  had  no  ef fect  on  e i ther  IgG-  or  C3b i -  
med ia ted  phagocytos i s  (not  shown) .  
The  data  presented  in f ig.3 conf i rm our  prev ious  
observat ions  that ,  in human neut roph i l s ,  IgG-  but  
not  C3b i -med ia ted  phagocytos i s  is a ca lc ium-  
dependent  process  [8]. However ,  even  more  impor -  
tant  is the  observat ion  that  phorbo l  es ter - induced 
act ivat ion  o f  p ro te in  k inase  C cou ld  s ign i f i cant ly  
res tore  the phagocyt ic  capac i ty  o f  IgG-opson ized  
part ic les  in cells w i th  an  impa i red  [Ca2+]i response  
(f ig.3).  In  add i t ion  to what  has  been d iscussed 
above ,  these  data  ind icate  that  p ro te in  k inase  C 
cou ld  also take  over  the cont ro l  o f  a process  that  
is normal ly  regu la ted  v ia  [Ca2+]i changes .  These  
observat ions  are,  consequent ly ,  in agreement  w i th  
the  genera l  idea o f  the  synerg is t ic  ac t ions  o f  a 
ra ised concent ra t ion  o f  cytoso l ic  free ca lc ium on  
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Fig.3. Effects of quin-2 buffering and PMA on C3bi- (open 
bar) and IgG-mediated (closed bar) phagocytosis in human 
neutrophils. Incubations with quinZ/AM (100 ,uM diluted to 
20pM after 10 min) were performed for a total of 60 min at 
37°C. This was followed by washing and incubation with 
opsonized yeast particles for 20 min at 37°C and then counting 
of the number of phagocytosed particles. In the situation where 
the modulatory effects of PMA (lo-’ M, hatched bar) were 
studied, the additive was given during the last 10 min of the 
quin-2 loading and also maintained during the subsequent 
incubation with opsonized yeast particles. Values given are 
means + SE of 6 separate experiments. Statistically significant 
modulation by PMA is indicated. The statistical tests were 
performed using Student’s r-test for paired samples. ** P < 
0.01. 
the one hand and activation of protein kinase C on 
the other [2,4]. 
Although protein kinase C catalyzes the 
phosphorylation of several proteins rather than 
just one, the finding by Vaux and Gordon [22] that 
a 19 kDa protein in macrophages is phosphory- 
lated, either as a result of phagocytosis or by ex- 
posure to PMA, lends further support for the 
view, suggested here, that protein kinase C activa- 
tion is involved in the transduction mechanism that 
regulates receptor-mediated phagocytosis. At 
present we cannot say whether protein kinase C 
controls receptor-mediated phagocytosis directly 
via phosphorylation of a certain target protein(s) 
or indirectly via stimulation of phospholipase AZ 
]231. 
PMA exposure has been shown to down- 
regulate cell surface receptors by enhanced en- 
docytosis [24-271. However, down-regulation of 
receptors for C3bi did not have any significant ef- 
fect on the phagocytic capacity of C3bi-opsonized 
particles in human neutrophils [24], This finding is 
in agreement with the present demonstration that 
PMA exposure alone did not impair C3bi- 
mediated phagocytosis (legend to fig. 1). However, 
the slight inhibition of PMA on IgG-mediated 
phagocytosis (legend to fig.2) could possibly be 
due to an inadequate number of cell surface recep- 
tors following PMA exposure. 
The observations made in this study suggest that 
activation of protein kinase C can control 
receptor-mediated engulfment in human neu- 
trophils. This is of particular importance, since we 
and others have shown that receptor-mediated 
phagocytosis can occur in the absence of calcium 
F&91. 
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